🔗 Permalink

Assignee profile:

CHIOME BIOSCIENCE INC.

City:

Tokyo

Country:

Japan

Published Applications:

Last publication date:

2025-05-15

Patent Grants:

Last grant date:

2023-02-07

Top Inventors for applications by CHIOME BIOSCIENCE INC.

These are the the leading inventors for applications assigned to CHIOME BIOSCIENCE INC.:

Koji Nakamura 7 Tokyo, Japan
Toru Kanke 3 Kanagawa, Japan
Kentaro Okamura 3 Kanagawa, Japan
Maki Tamura 3 Kanagawa, Japan

Hiroyuki Yanai 3 Kanagawa, Japan
Shankar Kumar 2 Pleasanton, CA United States
Takehiko Shibata 2 Saitama, Japan
Kunihiro Ohta 2 Saitama, Japan

Naoya Tsurushita 2 Palo Alto, CA United States
Kota Takahashi 2 Tokyo, Japan
Hidetaka Seo 2 Saitama, Japan
Akiko YOSHIOKA 2 Tokyo, Japan

Izumi SAKAGUCHI 2 Tokyo, Japan
Yosuke Kamimura 2 Tokyo, Japan
Masakazu YASHIRO 1 Osaka, Japan
Chika Koyama 1 Tokyo, Japan

Kotaro Yamamoto 1 Tokyo, Japan
Hitomi Sano 1 Tokyo, Japan
Hiroyuki Yanai 1 Tokyo, Japan
Shuichi Hashimoto 1 Tokyo, Japan

Keisuke Niikura 1 Tokyo, Japan
Donghui LI 1 Tokyo, Japan
Shoko Ishida 1 Tokyo, Japan
Nico MERTENS 1 Melsele, Belgium

Yurie YAMAMOTO 1 Osaka, Japan
Hidetaka Seo 1 Tokyo, Japan
Toshikazu INOUE 1 Tokyo, Japan
Ana Rita DA FONSECA RICARDO 1 Cascais, Portugal

Shu-ichi Hashimoto 1 Tokyo, Japan
Stefan IARUSSO 1 Berlin, Germany
Lingyi ZHANG 1 Tokyo, Japan
Isao Kohno 1 Tokyo, Japan

Philip Jeffrey CUNNAH 1 Cascais, Portugal
Naoto Harigai 1 Tokyo, Japan
Aki Takesue 1 Tokyo, Japan
Takayuki YOSHIMORI 1 Tokyo, Japan

Yukiko Banzai 1 Tokyo, Japan

Recent patent applications by CHIOME BIOSCIENCE INC.

CHIOME BIOSCIENCE INC. based in Tokyo, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-05-15

US20250154240A1

Chemistry; metallurgy

ANTI-HUMAN CXCL1 ANTIBODY

#2 | 2024-11-21

US20240383945A1

Chemistry; metallurgy

PURIFICATION METHOD OF ANTIBODY COMPOSITION

#3 | 2023-12-14

US20230398227A1

Human necessities

MEDICINE FOR TREATING CANCER

#4 | 2023-02-16

US20230050380A1

Chemistry; metallurgy

ANTI-CDCP1 ANTIBODY

#5 | 2022-06-23

US20220193064A1

Human necessities

MEDICAMENT FOR TREATING CANCER

#6 | 2019-11-28 ✅ Patent 11,572,402 granted on 2023-02-07

US20190359691A1

Chemistry; metallurgy

Method for promoting diversification of antibody variable region

#7 | 2019-08-01 ✅ Patent 11,008,566 granted on 2021-05-18

US20190233811A1

Chemistry; metallurgy

Method for obtaining antibody

#8 | 2017-11-30 ✅ Patent 10,941,207 granted on 2021-03-09

US20170342160A1

Chemistry; metallurgy

Fusion protein comprising three binding domains to 5T4 and CD3

#9 | 2016-11-17 ✅ Patent 10,202,461 granted on 2019-02-12

US20160333110A1

Chemistry; metallurgy

Anti-human TROP-2 antibody having an antitumor activity in vivo

#10 | 2016-02-25 ✅ Patent 9,670,287 granted on 2017-06-06

US20160053018A1

Chemistry; metallurgy

Anti-human TROP-2 antibody having anti-tumor activity in vivo

#11 | 2013-12-26 ✅ Patent 9,427,464 granted on 2016-08-30

US20130344509A1

Chemistry; metallurgy

Anti-human TROP-2 antibody having an antitumor activity in vivo

#12 | 2011-12-15 ✅ Patent 9,090,672 granted on 2015-07-28

US20110306126A1

Chemistry; metallurgy

Method for producing antibody directed against protein expressed on cell surface

#13 | 2011-03-24 ✅ Patent 8,187,884 granted on 2012-05-29

US20110070650A1

Chemistry; metallurgy

Method of enhancing homologous recombination of somatic cells and method of constructing specific antibody

#14 | 2006-05-11 ✅ Patent 9,587,251 granted on 2017-03-07

US20060099678A1

Chemistry; metallurgy

Method of inducing homologous recombination of somatic cell

Also check out CHIOME BIOSCIENCE INC.'s (Tokyo, Japan) applicant profile with 8 patent applications submitted.

AssigneeID:

217264 ⎘